Literature DB >> 17507435

Placental HIF-1 alpha, HIF-2 alpha, membrane and soluble VEGF receptor-1 proteins are not increased in normotensive pregnancies complicated by late-onset intrauterine growth restriction.

Augustine Rajakumar1, Arun Jeyabalan, Nina Markovic, Roberta Ness, Carol Gilmour, Kirk P Conrad.   

Abstract

Inadequate trophoblast invasion and spiral artery remodeling leading to poor placental perfusion are believed to underlie the pregnancy pathologies preeclampsia (PE) and intrauterine growth restriction (IUGR). The main objective of this study was to investigate hypoxia-inducible transcription factor-alpha (HIF-alpha) and downstream genes (VEGF receptor-1) Flt-1 and soluble fms-like tyrosine kinase 1 (sFlt-1) proteins in IUGR placentas. Placentas from normal pregnant (NP; n = 18), PE (n = 18), and IUGR (n = 10) patients were investigated. Normotensive patients with IUGR delivered babies at >or= 37 wk of gestation with birth weights of <10% and asymmetrical growth. HIF-1 alpha, -2 alpha, Flt-1, and sFlt-1 protein, and mRNA were assessed by Western and Northern blot analyses, respectively. The results are expressed as ratios of the densitometric values for each pair of pathologic and normal placentas, a ratio of 1.0 indicating no difference. Comparable to our earlier studies, the PE/NP ratios for HIF-1 alpha, -2 alpha, and Flt proteins were significantly increased by 50-100% (all P < 0.01 vs. 1.0). Unexpectedly, the IUGR/NP ratios for HIF-1 alpha and -2 alpha proteins were 1.03 +/- 0.07 and 0.96 +/- 0.16, respectively, and for Flt and sFlt were 1.14 +/- 0.15 and 0.95 +/- 0.12, respectively (all P = not significant vs. 1.0). Northern blot analysis revealed comparable levels of HIF-alpha mRNA in abnormal and normal placentas. In contrast to PE, HIF-alpha proteins and regulated genes are not increased in placentas from normotensive pregnant women delivering small, asymmetrically grown babies >or= 37 wk of gestation. The absence of an increase in HIF-alpha protein is not due to insufficient HIF-alpha mRNA for protein synthesis. Thus, the placentas from women with PE and late IUGR are fundamentally different at the molecular level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507435     DOI: 10.1152/ajpregu.00097.2007

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  26 in total

1.  Placental glucose transporter 3 (GLUT3) is up-regulated in human pregnancies complicated by late-onset intrauterine growth restriction.

Authors:  C Janzen; M Y Y Lei; J Cho; P Sullivan; B-C Shin; S U Devaskar
Journal:  Placenta       Date:  2013-08-28       Impact factor: 3.481

Review 2.  Emerging role for dysregulated decidualization in the genesis of preeclampsia.

Authors:  Kirk P Conrad; Maria Belen Rabaglino; Emiel D Post Uiterweer
Journal:  Placenta       Date:  2017-06-09       Impact factor: 3.481

Review 3.  Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia.

Authors:  Kirk P Conrad
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

4.  Intrauterine telemetry to measure mouse contractile pressure in vivo.

Authors:  Cara C Rada; Stephanie L Pierce; Chad A Grotegut; Sarah K England
Journal:  J Vis Exp       Date:  2015-04-06       Impact factor: 1.355

5.  Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors.

Authors:  Ana Sofia Cerdeira; Augustine Rajakumar; Caroline M Royle; Agnes Lo; Zaheed Husain; Ravi I Thadhani; Vikas P Sukhatme; S Ananth Karumanchi; Hernan D Kopcow
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

6.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

7.  The placenta in preeclampsia.

Authors:  James M Roberts; C Escudero
Journal:  Pregnancy Hypertens       Date:  2012-04-01       Impact factor: 2.899

8.  Increased myeloperoxidase in the placenta and circulation of women with preeclampsia.

Authors:  Robin E Gandley; Jennifer Rohland; Yan Zhou; Eiji Shibata; Gail F Harger; Augustine Rajakumar; Valerian E Kagan; Nina Markovic; Carl A Hubel
Journal:  Hypertension       Date:  2008-06-30       Impact factor: 10.190

9.  Leptin affects system A amino acid transport activity in the human placenta: evidence for STAT3 dependent mechanisms.

Authors:  F von Versen-Höynck; A Rajakumar; M S Parrott; R W Powers
Journal:  Placenta       Date:  2009-02-08       Impact factor: 3.481

Review 10.  Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy.

Authors:  K G Pringle; K L Kind; A N Sferruzzi-Perri; J G Thompson; C T Roberts
Journal:  Hum Reprod Update       Date:  2009-11-19       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.